Evans Adele Karen, Kazahaya Ken
Duke University Medical Center and Duke School of Medicine/Duke Children's Center, DUMC 3805, Durham, NC 27710, United States.
Int J Pediatr Otorhinolaryngol. 2007 Mar;71(3):367-74. doi: 10.1016/j.ijporl.2006.09.003. Epub 2006 Dec 29.
(1) Evaluate hearing results in patients managed with external auditory canal reconstruction; (2) compare results to the expectations from treatment with surgical; placement of an osteo-integrated bone-conduction device (BAHA system); (3) assess complications of both interventions; (4) evaluate the medical cost-effectiveness of each avenue of management at 2005 rates for billings based upon relative value units (RVUs).
(1) Retrospective chart review for 36 ears in 29 pediatric patients who underwent surgical canal reconstruction at a tertiary-care pediatric hospital in a major urban center with assessment of management techniques and surgical and audiologic outcomes. (2) Retrospective chart review of six pediatric patients who underwent BAHA placement in a major urban center with assessment of management techniques and surgical and audiologic outcomes. (3) Cost reassessment at 2005 billings rates based upon RVUs for canal reconstruction versus BAHA system and comparative analysis.
(1) The average post-operative hearing loss in the right ear was 34.3 dB left ear was 31.6 dB. The average gain per ear was 17.3 dB. (2) Twenty-seven (93%) of EAC reconstruction patients required some form of amplification post-operatively. (3) Data available for three of the BAHA patients reflected the predicted average gain in dB (predicted 34.3 dB, observed 31.8 dB). (4) Early complications of canal reconstruction included removal of the packing by the patient, post-operative bleeding and post-operative hematoma. (5) Late complications included recurrent canal stenosis, recurrent otitis externa, canal prolapse and canal cholesteatoma. (6) Uncomplicated external auditory canal reconstruction cost $51,505.98 or $2909.94/dB of hearing gain based upon billings fro RVUs. (7) Uncomplicated two-staged BAHA system placement cost $42,448.85 or $1237.57/dB of hearing gain based upon billings for RVUs. (8) Uncomplicated single-staged BAHA system placement cost $28,341.00 or $826.27/dB of hearing gain based upon billings for RVUs.
Study results indicate that even with significant investments in EAC reconstruction, most patients still required some form of amplification. There are also significant risks of early and late complications from the reconstructive procedure. Studies indicate and our results support that the osteo-integrated bone-conduction device (BAHA system) can achieve truly acceptable hearing (<or=15 dB) in school-aged children with normal bone curves, and it can match the bone-curves for children with sensorineural hearing loss. The two-staged BAHA system placement may be provided at almost one-third the cost to the medical system, on a decibel-for-decibel basis. The single-stage BAHA system placement yields even greater cost savings at just over one-quarter of the cost of surgical EAC reconstruction on a decibel-for-decibel basis. Additionally, there are fewer complications and fewer follow-up visits for the care of the implant system. This is an added value to the parents and patient for the savings in opportunity costs related to the lost time at work and school for office visits and peri-operative care. Overall, it appears that osteo-integrated bone-conduction devices may provide a higher quality of outcome for patients while resulting in significant economic savings.
(1)评估外耳道重建患者的听力结果;(2)将结果与手术植入骨锚式骨导装置(骨锚式助听器系统)治疗的预期结果进行比较;(3)评估两种干预措施的并发症;(4)根据相对价值单位(RVUs),以2005年计费标准评估每种治疗途径的医疗成本效益。
(1)对一家位于主要城市中心的三级儿科医院接受手术耳道重建的29例儿科患者的36只耳朵进行回顾性病历审查,评估治疗技术以及手术和听力结果。(2)对在一个主要城市中心接受骨锚式助听器植入的6例儿科患者进行回顾性病历审查,评估治疗技术以及手术和听力结果。(3)根据RVUs以2005年计费标准对耳道重建与骨锚式助听器系统进行成本重新评估并进行比较分析。
(1)术后右耳平均听力损失为34.3dB,左耳为31.6dB。每只耳朵的平均增益为17.3dB。(2)27例(93%)外耳道重建患者术后需要某种形式的听力放大。(3)3例骨锚式助听器患者的可用数据反映了预测的平均增益分贝数(预测为34.3dB,观察到为31.8dB)。(4)耳道重建的早期并发症包括患者自行取出填塞物、术后出血和术后血肿。(5)晚期并发症包括复发性耳道狭窄、复发性外耳道炎、耳道脱垂和耳道胆脂瘤。(6)根据RVUs计费,无并发症的外耳道重建成本为51,505.98美元,即每获得1dB听力增益成本为2909.94美元。(7)根据RVUs计费,无并发症的两阶段骨锚式助听器系统植入成本为42,448.